$SSII
SS Innovations International, Inc. Stock $ssii

$ssii Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000121390024025140 Filed on March 22, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$6.851M	$1.363M	$5.880M
YoY Change
Cost Of Revenue	$3.873M	$1.545M	$5.166M
YoY Change	287.26%	389.32%	354.99%
Gross Profit	$2.978M	-$181.7K	$713.4K
YoY Change	482.52%	-42.44%	-162.83%
Gross Profit Margin	43.46%	-13.33%	12.13%
Selling, General & Admin	$2.611M	$15.27M	$5.165M
YoY Change	84.27%	1581.57%	316.78%
% of Gross Profit	87.69%		723.91%
Research & Development	$396.1K	$576.2K	$576.2K
YoY Change		689.71%	689.71%
% of Gross Profit	13.3%		80.76%
Depreciation & Amortization	$77.19K	-$64.60K	$162.6K
YoY Change	3285.48%	-2933.33%	1679.25%
% of Gross Profit	2.59%		22.79%
Operating Expenses	$5.696M	$15.85M	$21.38M
YoY Change	176.89%	1515.25%	773.58%
Operating Profit	-$2.718M	-$16.03M	-$20.67M
YoY Change	75.83%	1136.04%	476.83%
Interest Expense	$183.2K	-$208.3K	$523.4K
YoY Change	170.63%	357.97%	1049.5%
% of Operating Profit
Other Income/Expense, Net	-$80.27K	$120.0K	-$273.6K
YoY Change	-252.18%	-29.4%	-216.63%
Pretax Income	-$2.798M	-$16.12M	-$20.94M
YoY Change	39.62%	1274.82%	846.31%
Income Tax
% Of Pretax Income
Net Earnings	-$2.798M	-$16.12M	-$20.94M
YoY Change	39.62%	1274.82%	846.31%
Net Earnings / Revenue	-40.85%	-1182.44%	-356.17%
Basic Earnings Per Share	-$0.02		-$0.16
Diluted Earnings Per Share	-$0.02	-$0.10	-$0.16
COMMON SHARES
Basic Shares Outstanding	170.7M shares	169.1M shares
Diluted Shares Outstanding	170.7M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$948.2K	$2.022M	$2.022M
YoY Change	111.39%	49.65%	49.65%
Cash & Equivalents	$948.2K	$2.022M	$2.022M
Short-Term Investments
Other Short-Term Assets	$8.450M	$8.386M	$8.386M
YoY Change	97255.18%	96511.75%	96511.75%
Inventory	$6.162M	$6.327M	$6.327M
Prepaid Expenses
Receivables	$4.226M	$1.647M	$1.647M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$19.79M	$18.38M	$18.38M
YoY Change	262.58%	321.62%	321.62%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.062M	$790.2K	$2.990M
YoY Change	22505.22%	6831.87%	26124.39%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$0.00	$0.00
YoY Change
Total Long-Term Assets	$11.26M	$7.096M	$7.096M
YoY Change	123345.91%	62154.46%	62149.04%
TOTAL ASSETS
Total Short-Term Assets	$19.79M	$18.38M	$18.38M
Total Long-Term Assets	$11.26M	$7.096M	$7.096M
Total Assets	$31.05M	$25.48M	$25.48M
YoY Change	467.93%	482.85%	482.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.446M	$900.9K	$900.9K
YoY Change
Accrued Expenses	$5.553M	$2.330M	$2.330M
YoY Change	97325.44%	40783.51%	4448.82%
Deferred Revenue		$156.3K
YoY Change
Short-Term Debt	$8.657M	$6.019M	$6.019M
YoY Change	73.14%	50.47%	50.47%
Long-Term Debt Due		$0.00	$0.00
YoY Change
Total Short-Term Liabilities	$15.66M	$9.271M	$9.271M
YoY Change	205.99%	128.84%	128.84%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.846M	$1.910M	$1.910M
YoY Change
Total Long-Term Liabilities	$1.846M	$1.910M	$1.910M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$15.66M	$9.271M	$9.271M
Total Long-Term Liabilities	$1.846M	$1.910M	$1.910M
Total Liabilities	$17.51M	$11.18M	$11.18M
YoY Change	242.06%	175.99%	175.99%
SHAREHOLDERS EQUITY
Retained Earnings	-$38.13M	-$35.33M
YoY Change	200.33%	230.46%
Common Stock	$17.07K	$17.07K
YoY Change	160.9%	216.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$13.54M	$14.30M	$14.30M
YoY Change
Total Liabilities & Shareholders Equity	$31.05M	$25.48M	$25.48M
YoY Change	467.93%	482.85%	482.85%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$2.798M	-$16.12M	-$20.94M
YoY Change	39.62%	1274.82%	846.31%
Depreciation, Depletion And Amortization	$77.19K	-$64.60K	$162.6K
YoY Change	3285.48%	-2933.33%	1679.25%
Cash From Operating Activities	$1.338M	$258.3K	-$13.57M
YoY Change	-497.51%	-122.81%	845.28%
INVESTING ACTIVITIES
Capital Expenditures	$1.317M	$1.886M	$2.763M
YoY Change			1154.24%
Acquisitions
YoY Change
Other Investing Activities	-$2.890M	$4.533M	$464.0K
YoY Change	44.52%	-338.6%	-115.47%
Cash From Investing Activities	-$4.208M	$2.647M	-$2.299M
YoY Change	110.38%	-239.34%	-23.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$2.740M	-7.288M	$16.73M
YoY Change	91.06%	-288.35%	210.98%
NET CHANGE
Cash From Operating Activities	$1.338M	258.3K	-$13.57M
Cash From Investing Activities	-$4.208M	2.647M	-$2.299M
Cash From Financing Activities	$2.740M	-7.288M	$16.73M
Net Change In Cash	-$129.9K	-4.382M	$862.8K
YoY Change	-85.61%	-623.4%	-191.25%
FREE CASH FLOW
Cash From Operating Activities	$1.338M	$258.3K	-$13.57M
Capital Expenditures	$1.317M	$1.886M	$2.763M
Free Cash Flow	$21.06K	-$1.628M	-$16.34M
YoY Change	-106.26%		886.38%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Entity File Number EntityFileNumber	000-56608
CY2023	dei	Entity Registrant Name EntityRegistrantName	SS INNOVATIONS INTERNATIONAL, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-3478854
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	405, 3rd Floor
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	iLabs Info Technology Centre
CY2023	dei	Entity Address Address Line3 EntityAddressAddressLine3	Udyog Vihar, Phase III
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Gurugram, Haryana
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	122016
CY2023	dei	Entity Address Country EntityAddressCountry	IN
CY2023	dei	City Area Code CityAreaCode	+91
CY2023	dei	Local Phone Number LocalPhoneNumber	73375 53469
CY2023	dei	Security12b Title Security12bTitle	None
CY2023	dei	No Trading Symbol Flag NoTradingSymbolFlag	true
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	Yes
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	384536354	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	170724381	shares
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	dei	Auditor Name AuditorName	BF Borgers CPA PC
CY2023	dei	Auditor Firm AuditorFirmId	5041
CY2023	dei	Auditor Location AuditorLocation	Lakewood, CO
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2022276	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1504049	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	5010725	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	63492	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1647274	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	592313	usd
CY2022Q4	ssii	Notes Receivables Acquisition Current NotesReceivablesAcquisitionCurrent	3000000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	6327256	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	855777	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3375168	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	700920	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	18382700	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	6716551	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	790164	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	388820	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2199418	usd
CY2023Q4	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	2640341	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	7096386	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1959653	usd
CY2023Q4	us-gaap	Assets Assets	25479086	usd
CY2022Q4	us-gaap	Assets Assets	8676204	usd
CY2023Q4	us-gaap	Bank Overdrafts BankOverdrafts	6018926	usd
CY2022Q4	us-gaap	Bank Overdrafts BankOverdrafts	3123046	usd
CY2022Q4	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent	120880	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	288988	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	900903	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	618852	usd
CY2023Q4	ssii	Deferred Tax Liability Current DeferredTaxLiabilityCurrent	20482	usd
CY2022Q4	ssii	Deferred Tax Liability Current DeferredTaxLiabilityCurrent	20597	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2041372	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	253377	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	9270670	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11136752	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1910432	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1910432	usd
CY2023Q4	us-gaap	Liabilities Liabilities	11181102	usd
CY2022Q4	us-gaap	Liabilities Liabilities	11136752	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	170711881	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	170711881	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	53887738	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	53887738	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	17071	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	5389	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	5000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	5000	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2023Q4	ssii	Translation Adjustment TranslationAdjustment	-329100	usd
CY2022Q4	ssii	Translation Adjustment TranslationAdjustment	15521	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	49039341	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11005895	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	899917	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	899917	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-35329246	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14387269	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	14297984	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-2460547	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25479086	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8676204	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	5166263	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	968721	usd
CY2023	us-gaap	Gross Profit GrossProfit	713447	usd
CY2022	us-gaap	Gross Profit GrossProfit	489594	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	576168	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	83282	usd
CY2023	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	13425319	usd
CY2022	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	1135468	usd
CY2023	us-gaap	Salaries And Wages SalariesAndWages	2215620	usd
CY2022	us-gaap	Salaries And Wages SalariesAndWages	1698283	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5164713	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3251794	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	21381820	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	6168827	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-20668373	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-5679233	usd
CY2023	us-gaap	Interest Expense InterestExpense	523356	usd
CY2022	us-gaap	Interest Expense InterestExpense	161999	usd
CY2023	ssii	Origination Fees Nonoperating OriginationFeesNonoperating	-120000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	129758	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	239728	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-273599	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	77729	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-20941972	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5601504	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20941972	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5601504	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2023	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	128445575	shares
CY2022	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	40878824	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-20941972	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5601504	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-344621	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	15521	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-21286593	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5585983	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-20941972	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5601504	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	162624	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	128901	usd
CY2023	us-gaap	Interest Expense Other InterestExpenseOther	138541	usd
CY2023	us-gaap	Other Noncash Expense OtherNoncashExpense	600000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	13430704	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	865468	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	9200688	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1054302	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2238034	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	106093	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13572758	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5555345	usd
CY2023	us-gaap	Payments For Proceeds From Previous Acquisition PaymentsForProceedsFromPreviousAcquisition	-3000000	usd
CY2022	us-gaap	Payments For Proceeds From Previous Acquisition PaymentsForProceedsFromPreviousAcquisition	3000000	usd
CY2023	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	2640341	usd
CY2023	us-gaap	Proceeds From Payments For Long Term Loans For Related Parties ProceedsFromPaymentsForLongTermLoansForRelatedParties	104371	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2763385	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	220324	usd
CY2022	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	484510	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2299356	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2735814	usd
CY2022	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-145000	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	4000000	usd
CY2023	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts	-2051353	usd
CY2022	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts	2583798	usd
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	808244	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	1500431	usd
CY2022	us-gaap	Proceeds From Sale Of Treasury Stock ProceedsFromSaleOfTreasuryStock	26000	usd
CY2023	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	12360	usd
CY2023	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	22980000	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	100000	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	7000000	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	3000000	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	1670834	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	1910432	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	16734963	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9294395	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	862849	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1003236	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-344621	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	69189	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1504049	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	431624	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2022277	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1504049	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-166380	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	679610	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	53518	usd
CY2022	ssii	Stock Issued During Period Security Offerings StockIssuedDuringPeriodSecurityOfferings	26000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1739807	usd
CY2022	ssii	Adjustment To Capital Reserve AdjustmentToCapitalReserve	899917	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	15521	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5601504	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-2460547	usd
CY2023	ssii	Stock Issued During Period Value Recapitalization StockIssuedDuringPeriodValueRecapitalization	1041	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	23118541	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1597693	usd
CY2023	ssii	Stock Issued During Period Security Offerings StockIssuedDuringPeriodSecurityOfferings	432672	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	115	usd
CY2023	ssii	Stock Issued During Period Value Issued For Services1 StockIssuedDuringPeriodValueIssuedForServices1	6857024	usd
CY2023	ssii	Stock Issued During Period Value Commonwarrants Exercised StockIssuedDuringPeriodValueCommonwarrantsExercised	412056	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	50000	usd
CY2023	ssii	Share Based Compensation Arrangement By Share Based Payment Award Options Grants ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrants	5575987	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-344621	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-20941972	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	14297984	usd
CY2023	ssii	Working Capital Deficit WorkingCapitalDeficit	9112029	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-35329246	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-20941972	usd
CY2023	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	13425319	usd
CY2023	us-gaap	Depreciation Depreciation	162623	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Unrealized Currency Transaction Gains DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains	1668146	usd
CY2023	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2023-12-31
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	16980000	usd
CY2023	us-gaap	Line Of Credit Facility Maximum Amount Outstanding During Period LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod	16980	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	14300000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-2460547	usd
CY2023Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	4287615	usd
CY2022Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	592313	usd
CY2023Q4	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	2640341	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	3000000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	16980000	usd
CY2023Q4	us-gaap	Deposits Deposits	4960362	usd
CY2023	ssii	Percentage Of Common Stock Issued And Outstanding PercentageOfCommonStockIssuedAndOutstanding	0.95	pure
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Use of Estimates</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and expenses. The Company regularly evaluates estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates made by management.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q4	us-gaap	Inventory Net InventoryNet	6327256	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Concentration of Credit Risk</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash. The Company maintains its principal cash balance in United States financial institutions, where deposits are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. The Company also maintains cash balances maintained with banks in India, where balances are insured by Deposit Insurance and Credit Guarantee Corporation of India (DICGC) to the extent of approximately $6,100 per account and in the Bahamas, where deposits are insured by the Deposit Insurance Corporation Bahamas up to B$50,000 (equivalent to $50,000) per account. As of December 31,2023, the Company had $1,683,141 of deposits in excess of overall insurance coverage limits.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
CY2023Q4	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	6100	usd
CY2023Q4	us-gaap	Time Deposit Liability Above Us Insurance Limit TimeDepositLiabilityAboveUsInsuranceLimit	50000	bsd
CY2023Q4	us-gaap	Time Deposit Liability Above Us Insurance Limit TimeDepositLiabilityAboveUsInsuranceLimit	50000	usd
CY2023	us-gaap	Payments For Deposits PaymentsForDeposits	1683141	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	1668146	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	592313	usd
CY2023Q4	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	2640341	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1213596	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	760204	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	423432	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	371384	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	790164	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	388820	usd
CY2023	us-gaap	Depreciation Depreciation	162623	usd
CY2022	us-gaap	Depreciation Depreciation	128901	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1647274	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	900903	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	618852	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2041372	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	253377	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2942275	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	872229	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	900903	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	1668146	usd
CY2023	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	16980000	usd
CY2023Q4	us-gaap	Bank Overdrafts BankOverdrafts	6018926	usd
CY2022Q4	us-gaap	Bank Overdrafts BankOverdrafts	3123046	usd
CY2023	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	362056	usd
CY2023	ssii	Tax Credit Carryforward Expiration Dates TaxCreditCarryforwardExpirationDates	April 2026
CY2023	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	1829.25	usd
CY2019Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	2454.75	usd
CY2019Q3	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2223	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	1474.17	usd
CY2022Q4	us-gaap	Operating Lease Expense OperatingLeaseExpense	404.68	usd
CY2023	ssii	Monthly Space Rent MonthlySpaceRent	194	usd
CY2021Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	16528	usd
CY2023	ssii	Lease Expiration Date LeaseExpirationDate	March 2030
CY2023Q2	us-gaap	Area Of Land AreaOfLand	21600	sqm
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	12033	usd
CY2023Q4	us-gaap	Other Loans Payable OtherLoansPayable	1466463	usd
CY2022Q4	us-gaap	Other Loans Payable OtherLoansPayable	1570833	usd
CY2023Q4	us-gaap	Loans Payable LoansPayable	1466463	usd
CY2022Q4	us-gaap	Loans Payable LoansPayable	1570833	usd
CY2023Q2	us-gaap	Related Party Transaction Date RelatedPartyTransactionDate	2023-12-31
CY2023Q2	ssii	Working Capital WorkingCapital	20000000	usd
CY2023Q2	us-gaap	Common Stock Convertible Conversion Price Increase CommonStockConvertibleConversionPriceIncrease	0.74
CY2023Q4	ssii	Notes Receivables Acquisition Current NotesReceivablesAcquisitionCurrent		usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2022Q4	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet		usd
CY2023Q4	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent		usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2022	ssii	Origination Fees Nonoperating OriginationFeesNonoperating		usd
CY2022	us-gaap	Interest Expense Other InterestExpenseOther		usd
CY2022	us-gaap	Other Noncash Expense OtherNoncashExpense		usd
CY2022	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable		usd
CY2022	us-gaap	Proceeds From Payments For Long Term Loans For Related Parties ProceedsFromPaymentsForLongTermLoansForRelatedParties		usd
CY2023	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets		usd
CY2023	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable		usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2023	us-gaap	Proceeds From Sale Of Treasury Stock ProceedsFromSaleOfTreasuryStock		usd
CY2022	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants		usd
CY2022	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt		usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2022Q4	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001676163

Files In Submission

Name	View Source	Status
0001213900-24-025140-index-headers.html	Edgar Link	pending
0001213900-24-025140-index.html	Edgar Link	pending
0001213900-24-025140.txt	Edgar Link	pending
0001213900-24-025140-xbrl.zip	Edgar Link	pending
ea0201951-10k_ssinnova.htm	Edgar Link	pending
ea020195101ex21-1_ssinnova.htm	Edgar Link	pending
ea020195101ex31-1_ssinnova.htm	Edgar Link	pending
ea020195101ex31-2_ssinnova.htm	Edgar Link	pending
ea020195101ex32-1_ssinnova.htm	Edgar Link	pending
ea020195101ex32-2_ssinnova.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ea0201951-10k_ssinnova_htm.xml	Edgar Link	completed
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ssii-20231231.xsd	Edgar Link	pending
ssii-20231231_def.xml	Edgar Link	unprocessable
ssii-20231231_cal.xml	Edgar Link	unprocessable
ssii-20231231_lab.xml	Edgar Link	unprocessable
ssii-20231231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SSII
SS Innovations International, Inc. Stock $ssii

2024 Q1 Form 10-K Financial Statement

#000121390024025140 Filed on March 22, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SSII SS Innovations International, Inc. Stock $ssii

2024 Q1 Form 10-K Financial Statement

#000121390024025140 Filed on March 22, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SSII
SS Innovations International, Inc. Stock $ssii